Latest Renewable Fuels News

GrainCorp Limited reported robust first-half results for FY25, driven by a large East Coast Australia crop and solid operational execution, prompting an upgrade to full-year earnings guidance and an expanded share buy-back program.

Ampol Limited is divesting its retail electricity businesses in New Zealand and Australia to sharpen its focus on electric vehicle charging and renewable fuels, aiming for a leaner, more profitable energy future.

Ampol Limited has unveiled its 2025 strategic roadmap focusing on refinery upgrades, retail expansion, and energy transition initiatives, aiming to boost margins and operational efficiency.

SPC Global Holdings confirms FY2025 pro forma EBITDA guidance of A$29 million, driven by strong early post-merger performance and strategic initiatives including site consolidation and leadership renewal.

GrainCorp projects a solid FY25 with EBITDA guidance up to $320 million and announces a $50 million share buy-back, underpinned by robust East Coast Australian grain production despite regional variances.

Nufarm Limited’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strong growth in omega-3 canola and strategic cost-saving initiatives setting the stage for future expansion.

AdAlta Limited has bolstered its leadership team and progressed its 'East to West' cellular therapy strategy alongside its lead drug candidate AD-214, despite a tightening cash position. The company’s recent non-binding term sheet and new clinical data signal promising momentum in its biotech pipeline.

Knosys Limited reports a record Annual Recurring Revenue of $9.7 million, driven by major enterprise contract renewals, while gearing up for the March 2025 launch of its Libero Library App.

Stanmore Resources capped off 2024 with record saleable coal production of 13.8 million tonnes, exceeding guidance despite operational headwinds. Strong performances at South Walker Creek and Poitrel, alongside strategic financial moves and a pioneering renewable fuels trial, position the company well for 2025.